Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Vaccines news

Show

From To
Broadly neutralizing HIV antibodies pave the way for vaccine

A small number of people infected with HIV produce antibodies with an amazing effect: Not only are the antibodies directed against the own virus strain, but also against different sub-types of HIV that circulate worldwide. Researchers from the University of Zurich and University Hospital Zurich now reveal which factors are responsible for the human body forming such broadly neutralizing HIV antibodies, thereby opening new avenues for the development of an HIV vaccine.

Published
10 hours ago
From
Medical Xpress
Understanding the Rationale for the HVTN 702 Trial

What have scientists learned that helped inform the design of this pivotal AIDS vaccine study in South Africa?

Published
22 August 2016
From
Vax Report
It’s all go for a new HIV vaccine efficacy trial this year

A new efficacy trial for a vaccine to prevent HIV infection – only the seventh ever conducted in the history of the epidemic – will start

Published
19 July 2016
By
Gus Cairns
New vigour in HIV vaccine research evident at AIDS 2016

Current and forthcoming studies of vaccines to prevent HIV infection have created a new optimism that the long and challenging road to the development of such a vaccine has begun to take some promising turns. Updates on the search for preventive vaccines, presented at the 21st International AIDS Conference (AIDS 2016) in Durban, South Africa, included information on advances in the development of novel vaccines, and in the field of antibody mediated prevention (AMP).

Published
19 July 2016
From
AIDS 2016
Treatment Action Group: Pipeline Report 2016

Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development.

Published
15 July 2016
From
Treatment Action Group
HIV study confirms clinically viable vaccine paving the way for future treatments

In the study, researchers worked with a species of Old World monkeys, rhesus macaques to reproduce the trial results of RV144, the only HIV vaccine that has been tested and shown to reduce the rate of HIV acquisition in a phase III clinical trial.

Published
08 July 2016
From
Eurekalert Inf Dis
Five Exciting HIV Prevention Studies We’re Paying Attention To

What’s on the horizon of HIV prevention? Here are five clinical trials to pay attention to, if you’re interested in what the next big breakthrough in the HIV prevention field may be.

Published
30 June 2016
From
BETA blog
Improving the Effect of HIV Drugs by Use of the Tat Vaccine

A phase II clinical trial conducted in South Africa has confirmed that the therapeutic Tat vaccine against HIV/AIDS can effectively improve the response to antiretroviral drugs in people living with HIV. The results are published today in the peer-review open access Journal Retrovirology.

Published
13 June 2016
From
Istituto Superiore di Sanità press release
Men to get HPV vaccine in new drive to combat cancer, announces health minister Jane Ellison

The first men in England have started receiving the vaccination as part of a pilot to stamp out cancers and genital disease. The scheme went live in two clinics this week and will eventually see 40,000 men vaccinated to protect them against penile, anal and other cancers. The project is specifically targeted at men who have sex with men, but ministers are exploring the possibility of rolling out the HPV vaccine to all boys.

Published
08 June 2016
From
Evening Standard
New HIV-Mimicking Particles That Trigger Immune Response Could Advance AIDS Vaccine Design

Researchers with the International Aids Vaccine Initiative (IAVI) and The Scripps Research Institute (TSRI) have built tiny particles that resemble HIV on their outside and used them to provoke an immune response in animals. Their work, which was published today in the journal Cell Reports, could advance the design of an effective AIDS vaccine.

Published
23 May 2016
From
IAVI
← First12345...34Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close